Company Features and Development Potential Among the existing 12 drugs, 5 are drugs with national drug invention patents and independent intellectual property rights, and the patent protection period will be 2022. Other drugs are all national new drugs. Except Gandakang Granules, 1 1 has exclusive domestic production rights. 1, Xingpi Yang Er Granule (national patent medicine and national basic medical insurance medicine) 2, Feilike Mixture (national patent medicine and national basic medical insurance medicine) 3, Feilike Capsule (national patent medicine and national basic medical insurance medicine) 4, Gandakang Granule (national new medicine and national basic medical insurance medicine) 5, Yulan Jiangtang Capsule (national patent medicine) Xingpi Yang Er Capsule (national patent medicine) Gong Li Quhuo Capsule (national new drug) 8. Yuan Zhi Dripping Pills (National New Drug) 9. Jianyang Capsule (national new drug) 10, Ganmao Dropping Pill (national new drug) 1 1, Chuanxiong Chatiao Dropping Pill (national new drug) 65438+